Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member, CEO
Jack Yongfeng Zhang
Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsAbout Jack Yongfeng Zhang
Jack Yongfeng Zhang is recorded as Board Member and CEO at Amphastar Pharmaceuticals, Inc. (AMPH). The newest filing on record that lists Jack Yongfeng Zhang as Board Member and CEO at Amphastar Pharmaceuticals, Inc. (AMPH) is dated April 15, 2020. The proxy statement of Amphastar Pharmaceuticals, Inc. reports total compensation of $5,969,742 for Jack Yongfeng Zhang in fiscal 2019, including a base salary of $897,585. Disclosed compensation is on record for 3 fiscal years. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes William J. Peters (CFO and Board Member), William Peters (CFO), Mary Ziping Luo (COO and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 15, 2020
-
Current
Start not stated–present
Last confirmed April 15, 2020
Company network
Leadership on record at Amphastar Pharmaceuticals, Inc.
- William J. Peters CFO, Board Member
- William Peters CFO
- Mary Ziping Luo COO, Board Member
- Jason B. Shandell General Counsel
- Anthony Pierce Board Member
- David Gaugh Board Member
- Gayle Deflin Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Executive Officer, President, Chief Scientific Officer and Director | $897,585 | $5,969,742 |
| 2018 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Executive Officer, President, Chief Scientific Officer and Director | $1,091,539 | $5,874,707 |
| 2017 | Amphastar Pharmaceuticals, Inc. (AMPH) | Chief Executive Officer, President, Chief Scientific Officer and Director | $880,000 | $5,755,532 |
Recent activity
No call appearances or filed executive changes recorded yet.